Education
About Us
Working with TipRanks
Follow Us
Alpha Cognition Inc (ACOG)
NASDAQ:ACOG
Earnings Data
Report Date
Aug 20, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.46Last Year’s EPS
-0.25Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 15, 2025
|% Change Since: -38.63%
|Next Earnings Date:Aug 20, 2025
Earnings Call Sentiment|Positive
The earnings call conveyed a largely positive sentiment, highlighting a successful launch of ZUNVEYL, strong financial position with a debt-free balance sheet, and promising partnerships and patent developments. The positive aspects were slightly tempered by the ongoing operating loss and lack of revenue guidance, but these did not overshadow the overall positive outlook.Company Guidance
During the Alpha Cognition earnings call, guidance for the fiscal year 2025 was provided with several key metrics highlighted. The company, led by Interim CFO Henry Du, reported a net loss reduction to $2 million, or $0.13 per share, compared to a $5 million loss, or $0.87 per share, in Q1 2024. Initial net product revenues from ZUNVEYL reached $347,000, with recognized licensing revenue of $2.6 million. Alpha Cognition maintained a strong balance sheet with $45.5 million in unrestricted cash and cash equivalents, and retired a $900,000 debt obligation. While revenue guidance was not provided, the company reiterated its full-year expense guidance in the range of $38 million to $42 million. The commercial launch of ZUNVEYL has shown promising early results, with approximately 500 bottles ordered and $1 million in net sales through April 30, despite launching without payer contracts. The company plans modest single-digit increases in headcount and anticipates moving to a positive cash flow position by year three, contingent on successful execution of its strategic plan.Commercial Launch of ZUNVEYL
The company successfully launched ZUNVEYL, a treatment for mild to moderate Alzheimer's disease, and reported $1 million in net sales just four weeks into the launch.
Partnership with CMS Pharmaceuticals
Alpha Cognition made significant progress with CMS Pharmaceuticals for ZUNVEYL distribution in China and other Asian territories, expecting regulatory submission in China by Q4 2025.
Financial Strength and Flexibility
The company ended the first quarter with approximately $45.5 million in unrestricted cash and cash equivalents, and successfully retired a $900,000 debt obligation, resulting in a debt-free balance sheet.
Patent Approvals
Received a new U.S. patent for pH-dependent release of benzgalantamine, providing additional protection through 2044, and submitted for patent extension on an early method of use patent.
Positive Market Feedback
Early market feedback for ZUNVEYL has been positive, with high prescriptions and minimal adverse events reported, indicating a strong start for the product.
ACOG Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ACOG Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 15, 2025 | $6.86 | $6.81 | -0.73% |
Mar 31, 2025 | $5.53 | $5.06 | -8.50% |
Nov 15, 2024 | $5.68 | $5.37 | -5.46% |
Aug 12, 2024 | $11.50 | $12.29 | +6.87% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Alpha Cognition Inc (ACOG) report earnings?
Alpha Cognition Inc (ACOG) is schdueled to report earning on Aug 20, 2025, TBA Not Confirmed.
What is Alpha Cognition Inc (ACOG) earnings time?
Alpha Cognition Inc (ACOG) earnings time is at Aug 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ACOG EPS forecast?
ACOG EPS forecast for the fiscal quarter 2025 (Q2) is -0.46.